These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3486010

  • 1. Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures.
    Estrov Z, Grunberger T, Chan HS, Freedman MH.
    Blood; 1986 May; 67(5):1382-7. PubMed ID: 3486010
    [Abstract] [Full Text] [Related]

  • 2. Cell culture studies and oncogene expression in juvenile chronic myelogenous leukemia.
    Gualtieri RJ, Castleberry RP, Gibbons J, Miller DM, Berkow RL, Parmley RT, Banks J.
    Exp Hematol; 1988 Aug; 16(7):613-9. PubMed ID: 2968914
    [Abstract] [Full Text] [Related]

  • 3. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia.
    Freedman MH, Cohen A, Grunberger T, Bunin N, Luddy RE, Saunders EF, Shahidi N, Lau A, Estrov Z.
    Br J Haematol; 1992 Jan; 80(1):40-8. PubMed ID: 1311195
    [Abstract] [Full Text] [Related]

  • 4. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD, Bates LJ, Zhu SW, Castleberry RP, Gualtieri RJ, Zuckerman KS.
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [Abstract] [Full Text] [Related]

  • 5. Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties.
    Freedman MH, Hitzler JK, Bunin N, Grunberger T, Squire J.
    Stem Cells; 1996 Nov; 14(6):690-701. PubMed ID: 8948026
    [Abstract] [Full Text] [Related]

  • 6. Residual juvenile chronic myelogenous leukemia cells detected in peripheral blood during clinical remission.
    Estrov Z, Dubé ID, Chan HS, Freedman MH.
    Blood; 1987 Nov; 70(5):1466-9. PubMed ID: 3478101
    [Abstract] [Full Text] [Related]

  • 7. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia.
    Gualtieri RJ, Emanuel PD, Zuckerman KS, Martin G, Clark SC, Shadduck RK, Dracker RA, Akabutu J, Nitschke R, Hetherington ML.
    Blood; 1989 Nov 15; 74(7):2360-7. PubMed ID: 2679915
    [Abstract] [Full Text] [Related]

  • 8. Thrombopoietin enhances the production of myeloid cells, but not megakaryocytes, in juvenile chronic myelogenous leukemia.
    Sawai N, Koike K, Higuchi T, Ogami K, Oda M.
    Blood; 1998 Jun 01; 91(11):4065-73. PubMed ID: 9596651
    [Abstract] [Full Text] [Related]

  • 9. Juvenile chronic myelogenous leukemia: in vitro characterization before and after allogeneic bone marrow transplantation.
    Zecca M, Rosti V, Pinto L, Comoli P, Carrà AM, Prete L, Bonetti F, Pedrazzoli P, Locatelli F, Cazzola M.
    Med Pediatr Oncol; 1995 Mar 01; 24(3):166-70. PubMed ID: 7838038
    [Abstract] [Full Text] [Related]

  • 10. Colony growth characteristics in chronic myelomonocytic leukemia.
    Geissler K, Hinterberger W, Bettelheim P, Haas O, Lechner K.
    Leuk Res; 1988 Mar 01; 12(5):373-7. PubMed ID: 3164085
    [Abstract] [Full Text] [Related]

  • 11. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice.
    Lapidot T, Grunberger T, Vormoor J, Estrov Z, Kollet O, Bunin N, Zaizov R, Williams DE, Freedman MH.
    Blood; 1996 Oct 01; 88(7):2655-64. PubMed ID: 8839860
    [Abstract] [Full Text] [Related]

  • 12. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N, Koike K, Ito S, Okumura N, Kamijo T, Shiohara M, Amano Y, Tsuji K, Nakahata T, Oda M.
    Exp Hematol; 1996 Feb 01; 24(2):116-22. PubMed ID: 8641332
    [Abstract] [Full Text] [Related]

  • 13. In vitro busulfan sensitivity of granulocyte-macrophage and erythroid progenitor cells in patients with chronic myelogenous leukemia.
    Kubota K, Preisler HD, Costanzo C, Miura Y.
    Cancer Res; 1983 Dec 01; 43(12 Pt 1):6090-3. PubMed ID: 6580066
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human interferon alpha-2 and juvenile chronic myelogenous leukemia: cell receptor binding, enzymatic induction, and growth suppression in vitro.
    Estrov Z, Lau AS, Williams BR, Freedman MH.
    Exp Hematol; 1987 Feb 01; 15(2):127-32. PubMed ID: 3102273
    [Abstract] [Full Text] [Related]

  • 15. Suppression of juvenile chronic myelogenous leukemia colony growth by interleukin-1 receptor antagonist.
    Schirò R, Longoni D, Rossi V, Maglia O, Doni A, Arsura M, Carrara G, Masera G, Vannier E, Dinarello CA.
    Blood; 1994 Jan 15; 83(2):460-5. PubMed ID: 8286744
    [Abstract] [Full Text] [Related]

  • 16. Constitutive expression of GATA-1, EPOR, alpha-globin, and gamma-globin genes in myeloid clonogenic cells from juvenile chronic myelocytic leukemia.
    Privitera E, Schirò R, Longoni D, Ronchi A, Rambaldi A, Bernasconi S, Ottolenghi S, Masera G, Biondi A.
    Blood; 1995 Jul 01; 86(1):323-8. PubMed ID: 7795240
    [Abstract] [Full Text] [Related]

  • 17. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY.
    J Immunol; 1986 Jun 15; 136(12):4487-95. PubMed ID: 3086433
    [Abstract] [Full Text] [Related]

  • 18. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
    Briggs M, Adams JA, Brereton ML, Burgess R, Hyde K, Lenehan H, Yin JA.
    Br J Haematol; 2001 Dec 15; 115(3):563-8. PubMed ID: 11736936
    [Abstract] [Full Text] [Related]

  • 19. Characterization of malignant peripheral blood cells of juvenile chronic myelogenous leukemia.
    Estrov Z, Zimmerman B, Grunberger T, Chao J, Teshima IE, Chan HS, Freedman MH.
    Cancer Res; 1986 Dec 15; 46(12 Pt 1):6456-61. PubMed ID: 3465439
    [Abstract] [Full Text] [Related]

  • 20. Congenital juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha-2.
    Hazani A, Barak Y, Berant M, Bar-Maor A.
    Med Pediatr Oncol; 1993 Dec 15; 21(1):73-6. PubMed ID: 8426579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.